Rapport Therapeutics, Inc. ($RAPP)
Filing Information
| Accession Number | 0001193125-26-429071 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 22, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
9,411
Total Value
$248,891.07
P&L
-5.3% ($13,145.52)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Oct 22, 2026 | Purchase | 8,239 | $26.38 | $217,344.00 | 8,239 | Indirect | By John M. Maraganore Revocable Trust | View Details | |
Director | Common Stock | โ | Oct 22, 2026 | Purchase | 1,172 | $26.92 | $31,547.08 | 9,411 | Indirect | By John M. Maraganore Revocable Trust | View Details |